GENE ONLINE|News &
Opinion
Blog

FDA approvals
Editors' Picks FDA Approval
Nearly 50 Cell and Gene Therapies Benefit From New FDA Flexibility
2026-01-12
CGT
Looking Back at the Cell and Gene Therapy Leaders That Made Waves in 2024
2025-03-31
Trials & Approvals FDA approvals 2025
Breaking New Ground in 2025 with 8 First-in-Class Drugs Close to FDA Approval – Part I
2025-03-31
LATEST
Oragenics Submits Annual Report Highlighting Fiscal Year 2025 Financials and Research Updates
2026-03-17
SurgePays Launches Nationwide Campaign to Promote LinkUp Mobile Service
2026-03-17
Tempus and Blood Cancer United Collaborate to Build Extensive Pediatric AML Data Registry
2026-03-17
John Choe Appointed Western Sales Director at Buzz Bomb Caffeine Company
2026-03-17
Two RXO Leaders Earn Fourth Consecutive Recognition in Supply Chain Pros to Know Awards
2026-03-17
Pfizer Reports Phase 2 Trial Success for Atirmociclib in Second-Line Metastatic Breast Cancer Treatment
2026-03-17
Merck to Present Long-Term Efficacy Data on GARDASIL9 and GARDASIL at EUROGIN 2026
2026-03-17
READ MORE
EVENT
2026-03-23
DCAT Week
New York, USA
2026-03-23
BIO Europe Spring (Biotech Partnering)
Lisbon, Portugal
2026-03-23
29th European Biotechnology Congress (Biotech R&D)
Rome, Italy
2026-04-09
4th Cell & Gene Therapy Innovation & Access Congress: Asia (Media Partnership)
Seoul, South Korea
2026-04-17
AACR Annual Meeting 2026 (Cancer Research & Early-Stage Breakthroughs)
San Diego, California
2026-04-29
BIO Korea 2026 (R&D & Collaborations)
Seoul, South Korea
SEE MORE
Scroll to Top